UEM-Vanderbilt Academic Partnership for Enhancements in Research (APER)
UEM-范德堡大学研究增强学术合作伙伴关系 (APER)
基本信息
- 批准号:10259747
- 负责人:
- 金额:$ 10.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-08 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS/HIV problemAcademic Medical CentersAddressAdultAfricaAfrica South of the SaharaAreaAwardBiomedical ResearchBiometryBiostatistics CoreCaliforniaClimateClinicCollaborationsCommunitiesComplementCountryDegree programDevelopmentEconomicsEducationEducational CurriculumEducational MaterialsEnsureEnvironmentEpidemiologyEuropeanEuropean UnionEvaluationExtramural ActivitiesFacultyFoundationsFundingGovernmentGraduate EducationGrantGrowthHIVHealthHealth ProfessionalHealth Services ResearchHealth educationHumanHuman DevelopmentInfrastructureInstitutesInstitutionInternationalInterventionInvestmentsLeadMedicalMedical ResearchMedicineMental HealthMentorsMozambiqueNew YorkPortuguesePrevalenceProfessional EducationPublic HealthPublicationsResearchResearch EthicsResearch PersonnelResearch ProposalsResearch TrainingResourcesScienceSeriesServicesStudentsTimeTrainingTraining ProgramsUNESCOUnited States National Institutes of HealthUniversitiesWarWomanWritingagedbasecareerdesigneducation researchexperienceglobal healthhealth care serviceimplementation researchimplementation scienceimprovedindexinginfrastructure developmentinnovationinstitutional capacitylow and middle-income countriesmedical schoolsprogramsrepositoryresponseservice deliveryskillsstemsuccesstraining opportunitytraining project
项目摘要
PROJECT SUMMARY/ ABSTRACT
The Republic of Mozambique, a Portuguese-speaking country of 28 million people on the southeast coast of
Africa, has experienced significant economic growth and distinct progress in improving health indicators over
the past two decades. Since the end of a devastating civil war in 1992, health has been a government priority,
particularly in response to the crushing burden of HIV/AIDS (the 2015 national prevalence was estimated at
13.2% among adults aged 15-49 years). The UN's 2018 Human Development Index ranks Mozambique 180th
out of the world's 189 countries.
While national efforts to expand HIV health care service delivery have focused on strengthening community-
based and regional clinics, there has simultaneously been significant targeted investment to build infrastructure
and human capacity in HIV research, innovation, and health education. Medical research, including
epidemiologic and health services research, has grown dramatically. This growth has stemmed from both
international collaborative projects, such as our current D43 Partnership for Research in Implementation
Science- Mozambique (PRISM) award between the Faculty of Medicine at University Eduardo Mondale (UEM)
and the Vanderbilt Institute for Global Health (VIGH) at Vanderbilt University Medical Center (VUMC), and also
from Mozambique's increased emphasis on research as a key component of professional and graduate
education in biomedical sciences and public health.
We seek to substantially build upon the groundwork laid by the PRISM collaboration for HIV implementation
science research capacity at UEM, Mozambique's principal medical school. Through a series of PRISM
evaluations, we have identified two areas for which UEM needs further infrastructure development to better
serve the growth in research initiatives. We propose here the UEM-Vanderbilt Academic Partnership for
Enhancements in Research (APER) program which will focus on further strengthening UEM´s local HIV
research capacity through targeted capacity building in Grants Management and Biostatistics, two significant
gaps identified in current capacity building activities.
Our Specific Aims are to 1) Promote sustainability and increased faculty competitiveness in grants
management through capacitation of the newly created UEM Office of Project Support in coordination with the
Faculty of Medicine Administration/Finance Office; and to 2) Develop a Biostatistics “Core” within UEM´s
Implementation Science Unit to provide biostatistics support to faculty and students in the conduct of their
research.
项目概要/摘要
莫桑比克共和国,一个拥有2800万人口的葡萄牙语国家,位于非洲东南沿海。
非洲经历了显着的经济增长,在改善健康指标方面取得了显着进展
自 1992 年毁灭性内战结束以来,健康一直是政府的首要任务,
特别是为了应对艾滋病毒/艾滋病的沉重负担(2015 年全国患病率估计为
15-49岁成年人中的这一比例为13.2%)联合国2018年人类发展指数将莫桑比克排在第180位。
世界 189 个国家中。
虽然国家扩大艾滋病毒卫生保健服务提供的努力侧重于加强社区——
总部和区域诊所同时进行了大量有针对性的投资来建设基础设施
以及人类在艾滋病毒研究、创新和健康教育方面的能力,包括医学研究。
流行病学和卫生服务研究的显着增长源于两者。
国际合作项目,例如我们当前的 D43 实施研究合作伙伴关系
爱德华多·蒙代尔大学 (UEM) 医学院授予莫桑比克科学 (PRISM) 奖
以及范德比尔特大学医学中心 (VUMC) 的范德比尔特全球健康研究所 (VIGH),以及
莫桑比克越来越重视研究作为专业和研究生的关键组成部分
生物医学科学和公共卫生教育。
我们力求充分利用 PRISM 合作为艾滋病毒实施奠定的基础
通过一系列 PRISM 提高莫桑比克主要医学院 UEM 的科学研究能力。
通过评估,我们确定了 UEM 需要进一步开发基础设施以更好地发展两个领域
我们在此提议建立 UEM-范德比尔特学术合作伙伴关系。
研究增强 (APER) 计划将重点关注进一步加强 UEM 当地的艾滋病毒
通过赠款管理和生物统计这两个重要领域的有针对性的能力建设来提高研究能力
确定了当前能力建设活动中的差距。
我们的具体目标是 1) 促进可持续性并提高教师在资助方面的竞争力
通过与新成立的 UEM 项目支持办公室的协调进行管理
医学管理学院/财务办公室;2) 在 UEM 内开发生物统计学“核心”
实施科学部门为教师和学生提供生物统计学支持
研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
D. Troy Moon其他文献
D. Troy Moon的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('D. Troy Moon', 18)}}的其他基金
Partnership for Research in Emerginig Viral Infections-Sierra Leone (PREVSL)
塞拉利昂新兴病毒感染研究伙伴关系 (PREVSL)
- 批准号:
10754357 - 财政年份:2023
- 资助金额:
$ 10.15万 - 项目类别:
Academic Partnership for Enhancements in Research (APER)
增强研究学术合作伙伴关系 (APER)
- 批准号:
10752791 - 财政年份:2023
- 资助金额:
$ 10.15万 - 项目类别:
UEM-Partnership for Research in Implementation Science Mozambique (PRISM).
UEM-莫桑比克实施科学研究伙伴关系(PRISM)。
- 批准号:
10755775 - 财政年份:2023
- 资助金额:
$ 10.15万 - 项目类别:
Partnership for Research in Emerginig Viral Infections-Sierra Leone (PREVSL)
塞拉利昂新兴病毒感染研究伙伴关系 (PREVSL)
- 批准号:
10613425 - 财政年份:2023
- 资助金额:
$ 10.15万 - 项目类别:
West Africa - Tulane University Laboratory Training Fellowship Supplement for Partnership for Research in Emerging Viral Infections Sierra Leone (PREVSL) U2RTW011248
西非 - 杜兰大学实验室培训奖学金补充塞拉利昂新发病毒感染研究伙伴关系 (PREVSL) U2RTW011248
- 批准号:
10876594 - 财政年份:2023
- 资助金额:
$ 10.15万 - 项目类别:
UEM-Vanderbilt Academic Partnership for Enhancements in Research (APER)
UEM-范德堡大学研究增强学术合作伙伴关系 (APER)
- 批准号:
10400635 - 财政年份:2020
- 资助金额:
$ 10.15万 - 项目类别:
UEM Partnership for Research in Implementation Science Mozambique (PRISM)
UEM 莫桑比克实施科学研究合作伙伴关系 (PRISM)
- 批准号:
9301949 - 财政年份:2015
- 资助金额:
$ 10.15万 - 项目类别:
UEM-Vanderbilt Partnership for Research in Implementation Science Mozambique (PRISM)
UEM-范德比尔特莫桑比克实施科学研究合作伙伴关系 (PRISM)
- 批准号:
10347355 - 财政年份:2015
- 资助金额:
$ 10.15万 - 项目类别:
Bacteremia in HIV-infected children under 5 years old hospitalized in Mozambique
莫桑比克住院的5岁以下感染艾滋病毒的儿童出现菌血症
- 批准号:
9306755 - 财政年份:2014
- 资助金额:
$ 10.15万 - 项目类别:
相似海外基金
Vanderbilt-Nigeria Biostatistics Training Program (VN-BioStat)
范德比尔特-尼日利亚生物统计学培训计划(VN-BioStat)
- 批准号:
10470510 - 财政年份:2022
- 资助金额:
$ 10.15万 - 项目类别:
The Hektoen Institute of Medical Research Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
Hektoen 医学研究所站点联盟 - HIV/艾滋病干预青少年医学试验网络 (ATN) 运营和合作中心(UM2 临床试验可选)
- 批准号:
10599560 - 财政年份:2022
- 资助金额:
$ 10.15万 - 项目类别:
Meharry HIV/AIDS Research and Training Facility
梅哈里艾滋病毒/艾滋病研究和培训设施
- 批准号:
10547968 - 财政年份:2022
- 资助金额:
$ 10.15万 - 项目类别:
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)
纽约大学疫苗和治疗评估中心(NYU VTEU)成立
- 批准号:
10493613 - 财政年份:2021
- 资助金额:
$ 10.15万 - 项目类别:
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)
纽约大学疫苗和治疗评估中心(NYU VTEU)成立
- 批准号:
10493604 - 财政年份:2021
- 资助金额:
$ 10.15万 - 项目类别: